These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 2670722)

  • 1. [Psychoactive drugs and cortical evoked potentials].
    Hegerl U
    Fortschr Neurol Psychiatr; 1989 Jul; 57(7):267-80. PubMed ID: 2670722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Classification of psychoactive drugs by visually evoked potentials in rabbits by means of multiple discriminant analysis. A possible way of predicting the clinical efficacy of new psychoactive drugs.
    Bock PR; Pollock B; Schach S; Fuchs A; Lohaus R
    Arzneimittelforschung; 1976; 26(7):1308-20. PubMed ID: 1036916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Use possibilities of quantitative electroencephalography in psychiatry and psychopharmacology].
    Fischer W; Rabending G; Heydenreich F; Herzer H; Altenstein R; Grimmberger E
    Samml Zwangl Abh Geb Psychiatr Neurol; 1982; 50():124-36. PubMed ID: 7157108
    [No Abstract]   [Full Text] [Related]  

  • 4. [Review of psychopharmacological treatments in adolescents and adults with autistic disorders].
    Baghdadli A; Gonnier V; Aussilloux C
    Encephale; 2002; 28(3 Pt 1):248-54. PubMed ID: 12091786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychotropic drugs and evoked potentials.
    Shagass C; Straumanis JJ; Roemer RA
    Electroencephalogr Clin Neurophysiol Suppl; 1982; 36():538-48. PubMed ID: 6130940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An absolute must in clinico-pharmacological research: pharmaco-electroencephalography, its possibilities and limitations.
    Herrmann WM; Irrgang U
    Pharmacopsychiatria; 1983 Sep; 16(5):134-42. PubMed ID: 6657739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New psychoactive drugs.
    Murray JB
    Genet Soc Gen Psychol Monogr; 1985 Nov; 111(4):429-53. PubMed ID: 2873081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Are psychoactive-drug-induced changes in plasma lipid and lipoprotein levels of significance for clinical remission in psychiatric disorders?
    Diebold K; Michel G; Schweizer J; Diebold-Dörsam M; Fiehn W; Kohl B
    Pharmacopsychiatry; 1998 Mar; 31(2):60-7. PubMed ID: 9562210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug prescribing pattern of a psychiatric university hospital in Germany.
    Schmidt LG; Niemeyer R; Müller-Oerlinghausen B
    Pharmacopsychiatria; 1983 Mar; 16(2):35-42. PubMed ID: 6867092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Acting out and psychoactive substances: alcohol, drugs, illicit substances].
    Gillet C; Polard E; Mauduit N; Allain H
    Encephale; 2001; 27(4):351-9. PubMed ID: 11686057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Psychotropic drugs, brain function and sleep. Neurophysiologic aspects of psychopharmacology and pharmacopsychiatry].
    Saletu B
    Bibl Psychiatr; 1976; (155):1-245. PubMed ID: 802167
    [No Abstract]   [Full Text] [Related]  

  • 12. Event-related potentials and the prediction of differential drug response in psychiatry.
    Hegerl U; Herrmann WM
    Neuropsychobiology; 1990; 23(2):99-108. PubMed ID: 2077439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Using antipsychotic agents in older patients.
    Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic drug monitoring of psychoactive drugs during pregnancy in the genomic era: challenges and opportunities.
    DeVane CL; Stowe ZN; Donovan JL; Newport DJ; Pennell PB; Ritchie JC; Owens MJ; Wang JS
    J Psychopharmacol; 2006 Jul; 20(4 Suppl):54-9. PubMed ID: 16785271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical study of cortical and brainstem evoked potentials in head injury].
    Nikaidou Y; Shimomura T; Hirabayashi H; Utsumi S; Kyoui K; Miyamoto S
    No Shinkei Geka; 1988 Nov; 16(12):1373-81. PubMed ID: 3226488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evoked potentials and electric resistance of the cerebral cortex under the effects of strychnine and atropine].
    Riabov SI; Kositsyn NS
    Biull Eksp Biol Med; 1992 May; 113(5):451-3. PubMed ID: 1421245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Polypharmacy in psychiatric patients as an alternative to limited mental health resources].
    de las Cuevas C; Sanz EJ; de la Fuente JA; Cueto M
    Actas Esp Psiquiatr; 2005; 33(2):81-6. PubMed ID: 15768314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Psychotherapeutic effects of psychotropic drugs: principle considerations from the psychobiologic viewpoint].
    Langer G
    Wien Med Wochenschr; 1986 Oct; 136(19-20):491-7. PubMed ID: 3027996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. On predicting therapeutic usefulness of psychotropic drugs from experiments in health persons.
    Spiegel R
    Rev Pure Appl Pharmacol Sci; 1980; 1(3):215-91. PubMed ID: 7025115
    [No Abstract]   [Full Text] [Related]  

  • 20. [Does the duration of medical consultations have an impact on the prescription of psychotropic drugs? Cross-sectional study carried out in general practice on 2,896 procedures].
    Kandel O; Ripault A; Jourdain M; Bouche G
    Rev Prat; 2008 Jun; 58(12 Suppl):19-24. PubMed ID: 18773661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.